Influence of infliximab pretreatment on ischemia/reperfusion injury in rat intestine.

The Pringle maneuver is used in hepatic surgery to prevent blood loss but is associated with ischemia- reperfusion injury. To investigate the effect of infliximab on inflammation and apoptosis in rat intestinal mucosa during ischemia-reperfusion (IR) injury. A total of 30 male Wistar albino rats were equally divided into three groups to be subjected to (i) sham operation (sham), (ii) IR injury via Pringle maneuver (pringle) or (iii) infliximab (IFX) group (IFX was given at a dose 3 mg/kg for 3 days before IR injury). Following reperfusion period of 60 min., intestinal tissue and blood samples were taken and processed by standard histological methods. The Pringle maneuver and following reperfusion caused significant histopathological changes, increased serum transaminases' activity and the levels of oxidative stress markers and decreased glutathione peroxidase activity. IFX pretreatment partially prevented these changes. Infliximab pretreatment may protect intestinal mucosa against ischemia-reperfusion injury. Further studies are needed to investigate mechanism and evaluate safety and optimal dosing of IFX in humans exposed to the possible tissue damage by ischemia-reperfusion.

[1]  M. Kanter,et al.  Anti-inflammatory and antioxidant effects of infliximab in a rat model of intestinal ischemia/reperfusion injury , 2012, Toxicology and industrial health.

[2]  A. Turan,et al.  The effect of rocuronium, sugammadex, and their combination on cardiac muscle and diaphragmatic skeletal muscle cells , 2012, Journal of Anesthesia.

[3]  C. Dejong,et al.  Total Intermittent Pringle Maneuver during Liver Resection Can Induce Intestinal Epithelial Cell Damage and Endotoxemia , 2012, PloS one.

[4]  A. Onder,et al.  The effects of ellagic acid on the liver and remote organs' oxidative stress and structure after hepatic ischemia reperfusion injury caused by pringle maneuver in rats. , 2012, Bratislavske lekarske listy.

[5]  Y. Tomak,et al.  Effects of sugammadex on immunoreactivity of calcineurin in rat testes cells after neuromuscular block: a pilot study , 2011, Journal of Molecular Histology.

[6]  A. Sturm,et al.  Current treatment of ulcerative colitis. , 2011, World journal of gastroenterology.

[7]  竹下 雅樹.  Role of transcription factors in small intestinal ischemia-reperfusion injury and tolerance induced by ischemic preconditioning , 2011 .

[8]  Jun Yao,et al.  Anti-oxidant effects of resveratrol on mice with DSS-induced ulcerative colitis. , 2010, Archives of medical research.

[9]  M. Menger,et al.  Intestinal ischemia/reperfusion: microcirculatory pathology and functional consequences , 2010, Langenbeck's Archives of Surgery.

[10]  A. Sipahi,et al.  Protective Effect of Octreotide and Infliximab in an Experimental Model of Indomethacin-Induced Inflammatory Bowel Disease , 2008, Digestive Diseases and Sciences.

[11]  Jordi Muntané,et al.  Mecanismos de lesión hepatocelular , 2007 .

[12]  Christopher H Contag,et al.  Inhibition of CD4+CD25+ regulatory T-cell function by calcineurin-dependent interleukin-2 production. , 2006, Blood.

[13]  H. Jaeschke.  Mechanisms of Liver Injury. II. Mechanisms of neutrophil-induced liver cell injury during hepatic ischemia-reperfusion and other acute inflammatory conditions. , 2006, American journal of physiology. Gastrointestinal and liver physiology.

[14]  M. Mantovani,et al.  Total hepatic ischemia and reperfusion after state controlled hemorrhagic shock, with used of different solutions: effects of neutrophils sequestration in kidney of rats. , 2006, Acta cirurgica brasileira.

[15]  E. Gozukara,et al.  Maternal and fetal plasma adenosine deaminase, xanthine oxidase and malondialdehyde levels in pre‐eclampsia , 2005, Cell biochemistry and function.

[16]  F. Kerdel,et al.  Tumor necrosis factor alpha inhibitors for the treatment of dermatologic diseases. , 2005, Dermatology nursing.

[17]  G. Corazza,et al.  Defective mucosal T cell death is sustainably reverted by infliximab in a caspase dependent pathway in Crohn’s disease , 2003, Gut.

[18]  P. Neuhaus,et al.  Ischemic preconditioning protects from hepatic ischemia/reperfusion-injury by preservation of microcirculation and mitochondrial redox-state. , 2003, Journal of hepatology.

[19]  Hartmut Jaeschke,et al.  Molecular mechanisms of hepatic ischemia-reperfusion injury and preconditioning. , 2003, American journal of physiology. Gastrointestinal and liver physiology.

[20]  P. Mertz,et al.  Calcineurin: form and function. , 2000, Physiological reviews.

[21]  A. Porter,et al.  Emerging roles of caspase-3 in apoptosis , 1999, Cell Death and Differentiation.

[22]  M. Al-Qattan.  Ischaemia-Reperfusion Injury , 1998 .

[23]  T. Aw.  Determinants of intestinal detoxication of lipid hydroperoxides. , 1998, Free radical research.

[24]  A. Rao,et al.  Calcineurin Binds the Transcription Factor NFAT1 and Reversibly Regulates Its Activity (*) , 1996, The Journal of Biological Chemistry.

[25]  T. Ishii,et al.  The Pringle maneuver induces only partial ischemia of the liver. , 1995, Hepato-gastroenterology.

[26]  M. Menger,et al.  Hepatic microcirculatory perfusion failure is a determinant of liver dysfunction in warm ischemia-reperfusion. , 1994, The American journal of pathology.

[27]  E. Squires,et al.  A comparative evaluation of thiobarbituric acid methods for the determination of malondialdehyde in biological materials. , 1993, Free radical biology & medicine.

[28]  R. Strieter,et al.  Interleukin-2-induced tumor necrosis factor-alpha (TNF-alpha) gene expression in human alveolar macrophages and blood monocytes. , 1989, The American review of respiratory disease.

[29]  Ernest Beutler,et al.  Red Cell Metabolism: A Manual of Biochemical Methods , 1975 .

[30]  H. Scott,et al.  Intestinal mucosal lesion in low-flow states. I. A morphological, hemodynamic, and metabolic reappraisal. , 1970, Archives of surgery.

[31]  W. Valentine,et al.  Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. , 1967, The Journal of laboratory and clinical medicine.